Latest filing published 22 Sept 2026 for Structure Therapeutics Inc., €108k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Crespo Blas Coll appears in our data through filings on Structure Therapeutics Inc. shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 18 September 2024 to 21 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 22 September 2026: a share grant of €108k, in Structure Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations